Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (54 quarters reported)
$3.02B in Q1 2013 → $1.17B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Ascendis Pharma A/s | 5.3% | New | 233,171 | $62.2M |
| Axsome Therapeutics Inc. | 4.6% | Trimmed 17% | 219,596 | $53.8M |
| EL Eli Lilly & Co | 4.0% | Trimmed 40% | 39,258 | $47.1M |
| Jazz Pharmaceuticals PLC | 3.3% | Trimmed 9.8% | 160,768 | $38.7M |
| Humana Inc | 3.2% | New | 94,375 | $37.5M |
| Unitedhealth Group Inc | 3.1% | Added 52% | 88,276 | $36.7M |
| Neurocrine Biosciences Inc | 3.1% | Trimmed 1.1% | 213,407 | $36M |
| Inhibrx Biosciences Inc | 2.5% | Added 1.0% | 308,385 | $29.2M |
| UT United Therapeutics Corp Del | 2.3% | Added 26% | 49,991 | $27.1M |
| Revolution Medicines Inc | 2.3% | Added 1.7% | 143,222 | $26.8M |
| IP Icon Pub Ltd Co | 2.0% | Added 137% | 136,482 | $23.7M |
| Tenet Healthcare Corp | 2.0% | Trimmed 68% | 126,572 | $23.7M |
| Edwards Lifesciences Corp | 1.9% | Trimmed 1.6% | 250,453 | $22.7M |
| Waters Corp | 1.9% | Added 50% | 59,825 | $22.4M |
| Penumbra Inc | 1.6% | Trimmed 57% | 60,221 | $19M |
| Bridgebio Pharma Inc | 1.6% | Trimmed 1.7% | 253,358 | $18.9M |
| Stryker Corporation | 1.5% | Added 158% | 56,637 | $17.8M |
| Mettler Toledo International | 1.5% | New | 13,344 | $17M |
| Indivior Pharmaceuticals Inc | 1.4% | Trimmed 30% | 401,208 | $16.5M |
| Merck & Co Inc | 1.4% | New | 127,118 | $16.3M |
| Cytokinetics Inc | 1.4% | New | 191,686 | $16.3M |
| LH Lantheus Hldgs Inc | 1.4% | New | 146,403 | $16.2M |
| CD Centene Corp Del | 1.4% | Trimmed 5.5% | 248,867 | $16M |
| CC Cooper Cos Inc | 1.4% | Added 30% | 220,890 | $15.8M |
| Madrigal Pharmaceuticals Inc | 1.4% | Trimmed 14% | 29,313 | $15.7M |
| AH Acadia Healthcare Company In | 1.3% | Trimmed 9.9% | 524,934 | $15.5M |
| Oruka Therapeutics Inc | 1.3% | Trimmed 8.7% | 158,825 | $15.1M |
| Oscar Health Inc | 1.3% | Added 3.8% | 519,016 | $14.8M |
| Thermo Fisher Scientific Inc | 1.2% | Added 92% | 28,496 | $14.3M |
| Cvs Health Corp | 1.2% | New | 137,457 | $14.2M |
| MM Merit Med Sys Inc | 1.2% | Added 21% | 197,038 | $13.7M |
| PP Praxis Precision Medicines I | 1.1% | Added 8.9% | 38,575 | $12.9M |
| CT Celldex Therapeutics Inc New | 1.1% | Added 5.5% | 342,751 | $12.8M |
| NA Novo-nordisk A S | 1.1% | Added 34% | 265,016 | $12.7M |
| IH Integer Hldgs Corp | 1.0% | Trimmed 6.2% | 126,669 | $11.8M |
| Dianthus Therapeutics Inc | 1.0% | Trimmed 30% | 121,222 | $11.8M |
| Definium Therapeutics Inc | 1.0% | Added 21% | 249,020 | $11.7M |
| Gilead Sciences Inc | 1.0% | New | 90,858 | $11.5M |
| Rhythm Pharmaceuticals Inc | 1.0% | Trimmed 26% | 101,550 | $11.3M |
| SH Schein Henry Inc | 1.0% | Trimmed 12% | 134,423 | $11.2M |
| AP Arrowhead Pharmaceuticals In | 0.9% | Added 105% | 131,667 | $10.7M |
| Tango Therapeutics Inc | 0.9% | Trimmed 20% | 326,047 | $10.2M |
| Teleflex Incorporated | 0.9% | New | 79,708 | $10.1M |
| Viking Therapeutics Inc | 0.9% | Trimmed 3.0% | 255,330 | $9.96M |
| BH Brightspring Health Svcs Inc | 0.8% | Trimmed 24% | 141,914 | $9.9M |
| Vera Therapeutics Inc | 0.8% | Added 28% | 224,289 | $9.62M |
| Roivant Sciences Ltd | 0.8% | Added 29% | 268,008 | $9.48M |
| Cg Oncology Inc | 0.8% | Trimmed 23% | 128,286 | $9.11M |
| Amneal Pharmaceuticals Inc | 0.7% | Trimmed 48% | 480,715 | $8.32M |
| Eupraxia Pharmaceuticals Inc | 0.7% | Added 124% | 1,210,661 | $8M |
| Cencora Inc Call | 0.7% | New | 28,100 | $7.95M |
| Irhythm Holdings Inc | 0.7% | New | 65,196 | $7.76M |
| Kodiak Sciences Inc | 0.6% | Added 69% | 193,315 | $7.53M |
| Abbott Laboratories | 0.6% | Trimmed 41% | 82,230 | $7.46M |
| WP West Pharmaceutical Svsc Inc | 0.6% | New | 20,733 | $7.44M |
| Takeda Pharmaceutical Co Ltd | 0.6% | New | 444,173 | $7.12M |
| Hinge Health Inc | 0.6% | New | 82,860 | $6.88M |
| Arcutis Biotherapeutics Inc | 0.5% | New | 242,069 | $6.35M |
| IL Integra Lifesciences Hldgs C | 0.5% | New | 348,746 | $6.26M |
| Illumina Inc | 0.5% | Added 21% | 35,040 | $6.16M |
Showing top 60 of 98 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Ascendis Pharma A/s | New | +233,171 | +$62.2M | 5.3% |
| SS SPDR Series Trust | Exited | −455,300 | −$58.2M | — |
| Tenet Healthcare Corp | Trimmed | −271,995 | −$50.9M | 2.0% |
| Humana Inc | New | +94,375 | +$37.5M | 3.2% |
| SS Select Sector SPDR Tr | Exited | −238,900 | −$35M | — |
| Ascendis Pharma A/s | Exited | −152,034 | −$34.8M | — |
| EL Eli Lilly & Co | Trimmed | −26,504 | −$31.8M | 4.0% |
| UT United Therapeutics Corp Del | Exited | −45,900 | −$27.2M | — |
| Penumbra Inc | Trimmed | −79,558 | −$25.1M | 1.6% |
| Glaukos Corp | Exited | −215,685 | −$23.2M | — |
Showing the 10 largest of 118 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR Series Trust | New | +455,300 | +$58.2M | 5.3% |
| SS Select Sector SPDR Tr | New | +238,900 | +$35M | 3.2% |
| UT United Therapeutics Corp Del | New | +45,900 | +$27.2M | 2.5% |
| Jazz Pharmaceuticals PLC | Added | +127,633 | +$24.1M | 3.1% |
| Adma Biologics Inc | Exited | −1,270,894 | −$23.2M | — |
| Medtronic PLC | Exited | −213,796 | −$20.5M | — |
| Merck & Co Inc | Exited | −187,834 | −$19.8M | — |
| UT United Therapeutics Corp Del | New | +31,700 | +$18.8M | 1.7% |
| Indivior Pharmaceuticals Inc | New | +574,666 | +$17.5M | 1.6% |
| UT United Therapeutics Corp Del | Trimmed | −27,938 | −$16.6M | 2.2% |
Showing the 10 largest of 101 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| EL Eli Lilly & Co | Trimmed | −156,850 | −$169M | 7.3% |
| SS SPDR Series Trust | Exited | −717,400 | −$71.9M | — |
| Mckesson Corp | Exited | −72,313 | −$55.9M | — |
| Axsome Therapeutics Inc | Trimmed | −278,770 | −$50.9M | 4.6% |
| Intuitive Surgical Inc | Trimmed | −61,993 | −$35.1M | 0.9% |
| Humana Inc | Exited | −110,000 | −$28.6M | — |
| Cencora Inc | Exited | −80,493 | −$25.2M | — |
| Hca Healthcare Inc | Trimmed | −51,908 | −$24.2M | 0.6% |
| Glaukos Corp | New | +201,676 | +$22.8M | 2.3% |
| Thermo Fisher Scientific Inc | Added | +35,601 | +$20.6M | 2.2% |
Showing the 10 largest of 103 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR Series Trust | New | +717,400 | +$71.9M | 5.5% |
| EL Eli Lilly & Co | Trimmed | −42,884 | −$32.7M | 13.2% |
| Danaher Corporation | Exited | −161,413 | −$31.9M | — |
| Humana Inc | New | +110,000 | +$28.6M | 2.2% |
| Humana Inc | Trimmed | −105,863 | −$27.5M | 0.1% |
| Molina Healthcare Inc | Exited | −85,739 | −$25.5M | — |
| UT United Therapeutics Corp Del | Added | +59,259 | +$24.8M | 3.1% |
| UH Universal Hlth Svcs Inc | New | +116,260 | +$23.8M | 1.8% |
| Alnylam Pharmaceuticals Inc | Exited | −72,220 | −$23.6M | — |
| CD Centene Corp Del | New | +574,360 | +$20.5M | 1.6% |
Showing the 10 largest of 81 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS Select Sector SPDR Tr | Exited | −429,700 | −$62.7M | — |
| Vertex Pharmaceuticals Inc | Exited | −126,989 | −$61.6M | — |
| Abbvie Inc | Trimmed | −290,959 | −$54M | 0.6% |
| Elevance Health Inc | Exited | −88,222 | −$38.4M | — |
| Argenx Se | Trimmed | −61,762 | −$34M | 0.3% |
| UH Universal Hlth Svcs Inc | Exited | −155,520 | −$29.2M | — |
| BD Becton Dickinson & Co | Exited | −91,571 | −$21M | — |
| TP Teva Pharmaceutical Inds Ltd | New | +1,238,846 | +$20.8M | 1.8% |
| Unitedhealth Group Inc | New | +65,000 | +$20.3M | 1.7% |
| IH Iqvia Hldgs Inc | Exited | −111,854 | −$19.7M | — |
Showing the 10 largest of 82 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Exited | −1,000,000 | −$92.5M | — |
| Edwards Lifesciences Corp | Exited | −525,400 | −$38.9M | — |
| Elevance Health Inc | New | +88,222 | +$38.4M | 2.8% |
| Unitedhealth Group Inc | Exited | −57,300 | −$29M | — |
| NA Novo-nordisk A S | Exited | −334,900 | −$28.8M | — |
| Dexcom Inc | Exited | −328,763 | −$25.6M | — |
| Alnylam Pharmaceuticals Inc | New | +87,145 | +$23.5M | 1.7% |
| Neurocrine Biosciences Inc | Exited | −166,803 | −$22.8M | — |
| IT Ishares Tr | Exited | −347,637 | −$21.7M | — |
| Bridgebio Pharma Inc | Added | +617,893 | +$21.4M | 2.3% |
Showing the 10 largest of 78 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cytokinetics Inc | Exited | −1,757,192 | −$92.8M | — |
| IT Ishares Tr | New | +1,000,000 | +$92.5M | 5.7% |
| SS Select Sector SPDR Tr | New | +464,700 | +$63.9M | 4.0% |
| Merck & Co Inc | Exited | −542,811 | −$61.6M | — |
| AH Acadia Healthcare Company In | Exited | −686,150 | −$43.5M | — |
| Edwards Lifesciences Corp | New | +525,400 | +$38.9M | 2.4% |
| Elevance Health Inc | Exited | −56,441 | −$29.3M | — |
| Amgen Inc | Exited | −90,297 | −$29.1M | — |
| Unitedhealth Group Inc | New | +57,300 | +$29M | 1.8% |
| NA Novo-nordisk A S | New | +334,900 | +$28.8M | 1.8% |
Showing the 10 largest of 82 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IQ Invesco Qqq Tr | Exited | −187,400 | −$89.8M | — |
| CD Centene Corp Del | Exited | −598,513 | −$39.7M | — |
| SS SPDR Ser Tr | Trimmed | −376,300 | −$37.2M | 1.2% |
| Unitedhealth Group Inc | Exited | −52,400 | −$26.7M | — |
| Dexcom Inc | Exited | −231,007 | −$26.2M | — |
| Edwards Lifesciences Corp | Trimmed | −349,397 | −$23.1M | 1.5% |
| Arcellx Inc | Trimmed | −251,378 | −$21M | 0.3% |
| IM Inspire Med Sys Inc | New | +98,322 | +$20.8M | 1.2% |
| Boston Scientific Corp | Trimmed | −239,638 | −$20.1M | 0.5% |
| Johnson & Johnson | Exited | −128,825 | −$18.8M | — |
Showing the 10 largest of 65 changes.
Loading...
